Yutaka Matsuyama

TL;DR: Variables associated with metastatic recurrence were factors to early phase recurrence; whereas those related with elevated carcinogenesis contributed to late phase recurrences, thus providing an epidemiological evidence that different mechanisms, i.e. metastasis and de novo, are involved in intrahepaticRecurrence after hepatectomy for HCC.

TL;DR: TACE showed safe therapeutic modality with a 5-year survival of 26% for unresectable HCC patients and both the degree of liver damage and the tumor-node-metastasis (TNM) system proposed by the Liver Cancer Study Group of Japan demonstrated good stratification of survivals.

TL;DR: An atomic resection for a single HCC yields more favorable results rather than nonanatomic resection, and multivariate analysis revealed that anatomic resection was a significantly favorable factor for overall and disease-free survivals.

TL;DR: Advances in the diagnosis and surgical treatment of hepatocellular carcinoma have improved the prognosis for patients with HCC who undergo liver resection, and a nationwide data base was evaluated to evaluate prognostic predictors.

TL;DR: The cumulative survival rates of newly registered patients in the 12th to 17th follow‐up surveys conducted between 1992 and 2003 were calculated for each histological type (HCC, ICC, and combined HCC and ICC) and stratified by background factors and treatment.